Treat- ment of non small cell lung cancer stage IV - ACCP Evidence Based Clinical Practice Guidelines. Chest 2007;132;277-89.Socinski MA, Crowell R, Hensing TE, Langer CJ, Lilenbaum R, Sandler AB et al (2007) Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based ...
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial. BACKGROUND:The aim of this study was to evaluate efficacy and toxicity of radioimmunotherapy with intensity-modulated radiation (IMRT) and cetuximab in sta... AD ...
Here, we sought to examine the impact of extended treatment delay for stage III-IV non–small-cell lung cancer on patient survival. Materials and Methods Using National Lung Screening Trial (NLST) and National Cancer Data Base (NCDB) data, Cox regression analysis with penalized smoothing splines...
Worldwide, lung cancer is the most common cause of cancer-related deaths. Molecular targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved outcomes markedly over the past two decades. However, the vast majority of adv
In a retrospective review, all patients diagnosed with stage IIIA, IIIB, and IV nonsmall cell lung cancer (NSCLC) between the years 1986 and 2001 at ... T Wang,RA Nelson,A Bogardus,... - 《Cancer》 被引量: 169发表: 2010年 Guidelines on Treatment of Stage IIIB Non-small Cell Lung ...
Table of Contents Non-Small Cell Lung Cancer Discussion *David S. Ettinger, MD/Chair † Matthew A. Gubens, MD, MS † Jose M. Pacheco, MD † The Sidney Kimmel Comprehensive UCSF Helen Diller Family University of Colorado Cancer Center Cancer Center at Johns Hopkins Comprehensive Cancer ...
Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results. 来自 NCBI 喜欢 0 阅读量: 29 作者:A Zaniboni,F Meriggi,A Rizzi,A Alghisi,G Marini 摘要: We have treated 26 consecutive chemotherapy-naive patients with stage IIIB/...
Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status i... S Nagel,R Califano,N Tha...
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer. Paclitaxel is an active single agent when administered as a 24-hour continuous infusion in the treatment of stage IV non-small-cell lung cancer. We evaluat... JD Hainsworth,DS Thompson,FA Greco - 《Jo...
The patients with T1-4, N0-3, Msite0-1 and adeno- or squamous carcinoma of stage IV NSCLC had a longer OS with local thoracic surgery in combination with chemotherapy or chemoradiation. Introduction Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in...